[Feasibility of establishment of rat model of bone cancer pain by using Walker 256 cells cultured in vitro or in vivo]
- PMID: 18756951
[Feasibility of establishment of rat model of bone cancer pain by using Walker 256 cells cultured in vitro or in vivo]
Abstract
Objective: To investigate the possibility of establishing rat model of bone cancer pain using cancer cells cultured in vitro or by ascites passaging and verify the reliability of this method.
Methods: Syngeneic SD rat carcinoma cells of the line Walker 256 were cultured in vitro and inoculated into the peritoneal cavity of SD rats respectively. Two kinds of Walker 256 cell suspension were made. Thirty-two SD rats were randomly divided into 4 equal groups: Group N (undergoing injection of Hank's solution into cavitas medullaris of left tibia), Group K (undergoing injection of heat-killed Walker 256 cells), Group V (injected with Walker 256 cells cultured in vitro), and Group A (injected with Walker 256 cells passaged in ascites). After 6, 12, and 18 days, the rats underwent roentgenography. Radio nuclide emission computed tomography (ECT) was conducted 12 days later. And MRI was conducted 15 days later. Thermal withdrawal latency (TWL) and pressure withdrawal threshold (PWT) were measured. Von Frey threshold and weight bearing of left hind limb were examined. On the 18th day after the establishment of model the rats were killed with their left tibia taken out to undergo microscopy.
Results: The rats of Groups A and V began to display decrease of left hint limb activity and roentgenography showed minute defect of bone trabecula in the proximal epiphysis by day 6. By day 12 roentgenography showed multiple defect of bone trabecula, ECT showed reactive bone formation. The rats of Groups A and V displayed signs of weight loss by day 14, and by day 18 roentgenography showed full thickness bicortical bone loss and formation of soft tissue tumor. Histological examination 18 days later revealed that the bones inoculated with live cells showed infiltration of bone marrow spaces by malignant tumor. The PWT values gradually decreased since day 6 to day 18, and the PWT values in this period of Groups A and V were all significantly lower than those of Groups K and N (all P < 0.01). The von Frey values gradually decreased since day 6 to day 18, and the von Frey values in this period of Groups A and V were all significantly lower than those of Groups K and N (all P < 0.01). The weight bearing value of left hind limb gradually decreased and the weight bearing difference between the 2 hind limbs gradually increased since day 6 to day 18, and the values of weight bearing difference between the 2 hind limbs of Groups A and V were significantly higher than those of Groups K and N (all P < 0.01). Sixteen rats underwent subcutaneous injection of morphine, and the PWT values increased 20, 30, and 40 min later in a dose-dependent manner (P < 0.01). Naloxone injected 1 h later antagonized the analgesic effect of morphine.
Conclusion: A SD rat model of bone cancer pain has been successfully established by using syngeneic rat bone carcinoma cells cultured in vitro or in vivo, and the latter being more convenient.
Similar articles
-
[Establishment and evaluation of a bone cancer pain model].Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2008 Feb;33(2):115-20. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2008. PMID: 18326905 Chinese.
-
[The cellular location and significance of p38alpha/beta isoforms in the lumbar spinal cord of the bone cancer pain rats].Zhonghua Yi Xue Za Zhi. 2007 Jan 2;87(1):53-7. Zhonghua Yi Xue Za Zhi. 2007. PMID: 17403314 Chinese.
-
[The role of brain-derived neurotrophic factor in pain facilitation and spinal mechanism in rat model of bone cancer pain].Zhonghua Yi Xue Za Zhi. 2011 May 10;91(17):1188-92. Zhonghua Yi Xue Za Zhi. 2011. PMID: 21756773 Chinese.
-
Bone cancer pain: from model to mechanism to therapy.J Pain Symptom Manage. 2005 May;29(5 Suppl):S32-46. doi: 10.1016/j.jpainsymman.2005.01.008. J Pain Symptom Manage. 2005. PMID: 15907645 Review.
-
Mechanisms that generate and maintain bone cancer pain.Novartis Found Symp. 2004;260:221-38; discussion 238-40, 277-9. Novartis Found Symp. 2004. PMID: 15283453 Review.
Cited by
-
Down-regulation of Toll-like receptor 4 gene expression by short interfering RNA attenuates bone cancer pain in a rat model.Mol Pain. 2010 Jan 20;6:2. doi: 10.1186/1744-8069-6-2. Mol Pain. 2010. PMID: 20089147 Free PMC article.
-
Nuclear factor kappa B regulated monocyte chemoattractant protein-1/chemokine CC motif receptor-2 expressing in spinal cord contributes to the maintenance of cancer-induced bone pain in rats.Mol Pain. 2018 Jan-Dec;14:1744806918788681. doi: 10.1177/1744806918788681. Epub 2018 Jun 29. Mol Pain. 2018. PMID: 29956585 Free PMC article.
-
Cancer-induced bone pain sequentially activates the ERK/MAPK pathway in different cell types in the rat spinal cord.Mol Pain. 2011 Jul 1;7:48. doi: 10.1186/1744-8069-7-48. Mol Pain. 2011. PMID: 21722369 Free PMC article.
-
P2Y12 receptor-mediated activation of spinal microglia and p38MAPK pathway contribute to cancer-induced bone pain.J Pain Res. 2017 Feb 16;10:417-426. doi: 10.2147/JPR.S124326. eCollection 2017. J Pain Res. 2017. PMID: 28243146 Free PMC article.
-
The Walker 256 Breast Cancer Cell- Induced Bone Pain Model in Rats.Front Pharmacol. 2016 Aug 31;7:286. doi: 10.3389/fphar.2016.00286. eCollection 2016. Front Pharmacol. 2016. PMID: 27630567 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical